MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

MD Anderson’s Tech Puts Replay on Fast Path to Clinic With TCR NK Cell Therapies

A slew of biotech companies are pursuing research that could overcome limitations of current cell therapies. Startup creator Replay has a new subsidiary pushing toward the front of the pack with a therapeutic candidate on track to start its first human test this summer—about one year after Replay emerged from stealth. It owes this rapid progress to a cell therapy pioneer’s technology that has already been de-risked by a big pharmaceutical company.
Replay calls itself a genome writing company. With operations split between San Diego and London, the private equity-backed business launched last July with $55 million and a suite of technologies…

Continue Reading
Readers Write: Faster Horses? Let’s Think Different

Readers Write: Faster Horses? Let’s Think Different

Faster Horses? Let’s Think Different By Stuart Hanson
Stuart Hanson, MBA is CEO of Avaneer Health of Chicago, IL.

American industrialist and business magnate Henry Ford is purported to have said, “If I had asked people what they wanted, they would have said faster horses.” The same could be said when it comes to what it’s going to take to transform the US healthcare system, one of the most administratively complex in the world.
When compared to other high-income nations, we spend the most, yet have poorer outcomes. While we have many initiatives in place to fix our current administrative…

Continue Reading
VitalSight by OMRON Preview at CES 2023

VitalSight by OMRON Preview at CES 2023

VitalSight is a new tool for remote patient monitoring (RPM) from OMRON, a company that offers a wide range of health devices for blood pressure, respiratory problems, and more. Brandon Haag, OMRON's Director of Operations and Business Development, describes in this short video the operation of VitalSight and how it helps both the patient and their doctor treat hypertension. OMRON is working on adding more sources of data and medical conditions to this program.Learn more about VitalSight by OMRON: https://omronhealthcare.com/vitalsight/Find more great health IT content: https://www.healthcareittoday.com/…

Continue Reading
UChicago to launch accelerator for AI and data science companies

UChicago to launch accelerator for AI and data science companies

The University of Chicago this week announced the creation of Transform, an accelerator for early-stage technology companies focused on data science and artificial intelligence.WHY IT MATTERSThe new program – which is part of the Deep Tech Ventures initiative at the UChicago’s Polsky Center for Entrepreneurship and Innovation – aims to offer a wide array of support to startups: access to business and technical training, industry mentorship, venture capital connections, and funding opportunities
Transform is seeking two cohorts of as many as 10 companies each. Candidates should be focused on information technologies and data science: AI and machine learning, data engineering, analytics and…

Continue Reading
Episode 10: A Look at the  Proposed HIPAA Changes

Episode 10: A Look at the Proposed HIPAA Changes

In this episode of Health+Tech, Andrea Lee Linna and Jonathan Ishee are joined by fellow McGuireWoods digital health team member Michael Paluzzi to discuss proposed HIPAA changes that may require covered entities and business associates to overhaul their HIPAA policies and procedures in 2022.After providing a high-level overview of the proposed changes, the podcast turns to a live recording of Andrea and Jonathan’s recent webinar, “Preparing for Major HIPAA Changes in 2022,” offering in-depth details about the proposed changes and how to prepare for them in the new year….

Continue Reading
Episode 9: Digital Health Trends and Issues for Life Sciences Companies

Episode 9: Digital Health Trends and Issues for Life Sciences Companies

In this episode of Health+Tech, McGuireWoods healthcare attorneys Janice Suchyta, Kate Hardey, Kae Gruner and Royce DuBiner discuss the latest digital health updates from the Food and Drug Administration and Federal Trade Commission. Join the conversation as we wrap up Cybersecurity Awareness Month and discuss the following topics:• FDA draft guidance on electronic health records and medical claims data• FDA new resource for approved artificial intelligence/machine learning medical devices• FDA Digital Health Center of Excellence• FTC rules for health apps outside of HIPAA…

Continue Reading